Specialized Commissioning Clinical Commissioning Policies Work Programme updated in England

In December 2022, NHS England published an update of the Specialized Services Policy Pipeline (as of December 6, 2022). No new MedTech-related Clinical Commissioning Policies were added to the work program.

The following three new MedTech-related Clinical Commissioning Policies were published in the period from September 6, 2022, to December 6, 2022:

• MR-guided laser interstitial thermal therapy for the treatment of epileptogenic zones in children and adults with refractory focal epilepsy is recommended to be available as a routine commissioning treatment option within the criteria set out in the policy document;
• Fresh osteochondral allograft for osteochondral lesions of the knee in adults and post-pubescent children is recommended to be available as a routine commissioning treatment option within the criteria set out in the policy document;
• Multi-grip myoelectric control prosthetic hand is recommended to be available as a routine commissioning treatment option for congenital upper limb deficiency or upper limb amputation within the criteria set out in the policy document.

The status of ongoing policies was updated as well.

See the full details here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).